Tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils): a systematic review and meta-analysis.

Author: CatesChris J, ChangAnne B, KewKayleigh M, PetskyHelen L

Paper Details 
Original Abstract of the Article :
Asthma guidelines guide health practitioners to adjust treatments to the minimum level required for asthma control. As many people with asthma have an eosinophilic endotype, tailoring asthma medications based on airway eosinophilic levels (sputum eosinophils or exhaled nitric oxide, FeNO) may improv...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1136/thoraxjnl-2018-211540

データ提供:米国国立医学図書館(NLM)

Tailoring Asthma Treatment: Finding the Right Oasis

Asthma is a complex chronic disease, and finding the right treatment for each individual can be challenging, like navigating a vast and ever-changing desert. This study, published in the field of

respiratory medicine

, explores the potential benefits of tailoring asthma treatment based on specific markers of eosinophilic inflammation, such as exhaled nitric oxide (FeNO) and sputum eosinophils. The researchers examined whether this personalized approach can lead to better asthma outcomes.

A Personalized Approach to Asthma Care

The study suggests that tailoring asthma treatment based on eosinophilic markers could improve asthma control and reduce the need for medications. This is like finding the right oasis in the desert, where different types of water sources are needed to support different types of camels. This personalized approach could potentially lead to better outcomes for asthma patients.

A More Comfortable Journey for Asthma Patients

This research offers a promising new direction for asthma care. By tailoring treatment based on individual markers of inflammation, doctors can potentially provide more effective and targeted treatment, leading to a more comfortable and controlled journey for those with asthma. It's a step towards finding the right path to better manage this chronic condition.

Dr. Camel's Conclusion

This study, like a caravan finding the best route across a vast desert, highlights the importance of a personalized approach to asthma treatment. The study suggests that tailoring treatment based on eosinophilic markers could potentially improve asthma control and lead to better outcomes. It's a reminder that even in the seemingly barren desert of asthma treatment, there can be hidden oases of hope and effective care.

Date :
  1. Date Completed 2019-04-09
  2. Date Revised 2019-04-09
Further Info :

Pubmed ID

29858277

DOI: Digital Object Identifier

10.1136/thoraxjnl-2018-211540

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.